Visual agnosia
Visual agnosia is a rare neurological disorder characterized by the loss of the ability to recognize objects, faces, places, or even one's own body parts. Despite having normal vision, individuals with visual agnosia struggle to process visual information, leading to significant difficulties in daily life.
Types of Visual Agnosia[edit]
Visual agnosia can be broadly classified into two types: Apperceptive agnosia and Associative agnosia.
Apperceptive Agnosia[edit]
In Apperceptive agnosia, the individual struggles to perceive the structure and features of objects, even though their basic visual functions such as color and motion perception remain intact. They may struggle to copy drawings or distinguish between different shapes.
Associative Agnosia[edit]
In contrast, individuals with Associative agnosia can perceive the structure and features of objects but fail to recognize what the object is. They can draw and describe objects but cannot identify them.
Causes[edit]
Visual agnosia is typically caused by damage to the posterior part of the brain, particularly the occipital lobe or the temporal lobe. This damage can occur due to a variety of reasons, including stroke, brain injury, neurodegenerative diseases, or carbon monoxide poisoning.
Diagnosis[edit]
Diagnosis of visual agnosia involves a thorough neurological examination, including tests of visual perception. The Birmingham Object Recognition Battery (BORB) is a commonly used test in the diagnosis of visual agnosia.
Treatment[edit]
There is currently no cure for visual agnosia. Treatment primarily involves occupational therapy and strategies to help the individual cope with their visual difficulties.
See Also[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
